Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
84.80
-3.60 (-4.07%)
Sep 9, 2025, 2:36 PM CST

Excelsior Medical Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
8,6548,5398,2337,1876,5736,675
Upgrade
8,6548,5398,2337,1876,5736,675
Upgrade
Revenue Growth (YoY)
2.95%3.71%14.56%9.34%-1.53%3.38%
Upgrade
Cost of Revenue
6,7816,7576,5645,6735,1995,369
Upgrade
Gross Profit
1,8731,7811,6701,5141,3741,307
Upgrade
Selling, General & Admin
1,0871,032973.59893.28770.54774.52
Upgrade
Other Operating Expenses
0.19-4.14-5.850.931.410.08
Upgrade
Operating Expenses
1,0771,028966.84907.43779777.5
Upgrade
Operating Income
795.77753.32702.88606.61595.03529.07
Upgrade
Interest Expense
-24.88-18.65-14.32-5.93-3.65-7.44
Upgrade
Interest & Investment Income
98.1393.5678.8544.9930.0146.49
Upgrade
Earnings From Equity Investments
354.26323.19342.3290.24233.43242.03
Upgrade
Currency Exchange Gain (Loss)
6.36.3-1.627.78-0.950.74
Upgrade
Other Non Operating Income (Expenses)
-10.5214.0316.2621.2225.1418.6
Upgrade
EBT Excluding Unusual Items
1,2191,1721,124964.9879.01829.48
Upgrade
Gain (Loss) on Sale of Investments
1.861.86-0.69-1.76-6.64-
Upgrade
Gain (Loss) on Sale of Assets
0.760.7620.420.16-0.01-0.1
Upgrade
Other Unusual Items
---0.41.37-
Upgrade
Pretax Income
1,2221,1741,144963.7873.74829.38
Upgrade
Income Tax Expense
226.59203.31221.23178.4151.45160.3
Upgrade
Earnings From Continuing Operations
995.09971.06922.85785.3722.29669.09
Upgrade
Minority Interest in Earnings
-204.32-199.8-176.25-117.85-115.14-97.42
Upgrade
Net Income
790.77771.26746.61667.45607.15571.67
Upgrade
Net Income to Common
790.77771.26746.61667.45607.15571.67
Upgrade
Net Income Growth
1.74%3.30%11.86%9.93%6.21%11.06%
Upgrade
Shares Outstanding (Basic)
172172172172172171
Upgrade
Shares Outstanding (Diluted)
172172172172172172
Upgrade
Shares Change (YoY)
-0.04%0.01%-0.09%-0.05%0.34%9.73%
Upgrade
EPS (Basic)
4.614.504.353.893.543.34
Upgrade
EPS (Diluted)
4.594.484.333.873.523.32
Upgrade
EPS Growth
1.63%3.30%11.88%10.16%5.78%1.25%
Upgrade
Free Cash Flow
601.172,357-19.27465.53780.36838.72
Upgrade
Free Cash Flow Per Share
3.4913.68-0.112.704.524.88
Upgrade
Dividend Per Share
3.8003.6193.4473.1532.8792.880
Upgrade
Dividend Growth
10.25%5.00%9.31%9.50%-0.00%6.06%
Upgrade
Gross Margin
21.64%20.86%20.28%21.07%20.90%19.57%
Upgrade
Operating Margin
9.20%8.82%8.54%8.44%9.05%7.93%
Upgrade
Profit Margin
9.14%9.03%9.07%9.29%9.24%8.56%
Upgrade
Free Cash Flow Margin
6.95%27.60%-0.23%6.48%11.87%12.56%
Upgrade
EBITDA
1,015946.62866.09741.45717.68616.34
Upgrade
EBITDA Margin
11.73%11.09%10.52%10.32%10.92%9.23%
Upgrade
D&A For EBITDA
218.99193.3163.21134.84122.6587.27
Upgrade
EBIT
795.77753.32702.88606.61595.03529.07
Upgrade
EBIT Margin
9.20%8.82%8.54%8.44%9.05%7.93%
Upgrade
Effective Tax Rate
18.55%17.31%19.34%18.51%17.33%19.33%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.